| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $492.4M | +27.3% |
| Cost of Revenue | $147.6M | +20.9% |
| Gross Profit | $344.8M | +30.2% |
| R&D Expense | $60.6M | +50.4% |
| SG&A Expense | $84.8M | +31.7% |
| Operating Income | -$99.5M | -288.9% |
| Interest Expense | $3.3M | -40.9% |
| Pre-tax Income | -$104.6M | -205.8% |
| Income Tax | $6.9M |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $321.4M | +372.4% |
| Current Assets | $805.3M | +63.4% |
| Total Assets | $920.0M | +57.0% |
| Current Liabilities | $395.1M | +31.0% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $404.2M | +0.3% |
| Stockholders' Equity | $515.8M | +182.3% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.9M | -550.3% |
| Capital Expenditures | $6.1M | +127.6% |
| Investing Cash Flow | -$15.7M | +92.9% |
| Financing Cash Flow | $303.1M | +12.4% |
| Free Cash Flow | -$39.1M | -947.5% |
| +83.1% |
| Net Income | -$111.5M | -193.6% |
| EPS (Basic) | -$0.57 | -35.7% |
| EPS (Diluted) | -$0.57 | -35.7% |